欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0554/002
药品名称LUNIDOC
活性成分
    • nintedanib esilate 150.0 mg
剂型Capsule, soft
上市许可持有人Adalvo Limited Malta Life Sciences Park, Building 1, Level 4 Sir Temi Zammit Buildings San Gwann Industrial Estate San Gwann SGN 3000 Malta
参考成员国 - 产品名称Iceland (IS)
LUNIDOC
互认成员国 - 产品名称
    • Cyprus (CY)
      LUNIDOC 150 mg μαλακά καψάκια
    • Malta (MT)
      Lunidoc 150mg soft capsules
许可日期2023/12/21
最近更新日期2023/12/21
药物ATC编码
    • L01EX09 nintedanib
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase